TW200505905A - New compounds - Google Patents
New compoundsInfo
- Publication number
- TW200505905A TW200505905A TW092134210A TW92134210A TW200505905A TW 200505905 A TW200505905 A TW 200505905A TW 092134210 A TW092134210 A TW 092134210A TW 92134210 A TW92134210 A TW 92134210A TW 200505905 A TW200505905 A TW 200505905A
- Authority
- TW
- Taiwan
- Prior art keywords
- compounds
- phenyl
- active compounds
- membered heteroaromatic
- heteroaromatic ring
- Prior art date
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D403/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00
- C07D403/02—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00 containing two hetero rings
- C07D403/06—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00 containing two hetero rings linked by a carbon chain containing only aliphatic carbon atoms
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D403/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00
- C07D403/02—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00 containing two hetero rings
- C07D403/12—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00 containing two hetero rings linked by a chain containing hetero atoms as chain links
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P15/00—Drugs for genital or sexual disorders; Contraceptives
- A61P15/16—Masculine contraceptives
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P15/00—Drugs for genital or sexual disorders; Contraceptives
- A61P15/18—Feminine contraceptives
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P17/00—Drugs for dermatological disorders
- A61P17/14—Drugs for dermatological disorders for baldness or alopecia
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P21/00—Drugs for disorders of the muscular or neuromuscular system
- A61P21/02—Muscle relaxants, e.g. for tetanus or cramps
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/14—Drugs for disorders of the nervous system for treating abnormal movements, e.g. chorea, dyskinesia
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/14—Drugs for disorders of the nervous system for treating abnormal movements, e.g. chorea, dyskinesia
- A61P25/16—Anti-Parkinson drugs
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/18—Antipsychotics, i.e. neuroleptics; Drugs for mania or schizophrenia
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/24—Antidepressants
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/28—Drugs for disorders of the nervous system for treating neurodegenerative disorders of the central nervous system, e.g. nootropic agents, cognition enhancers, drugs for treating Alzheimer's disease or other forms of dementia
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P3/00—Drugs for disorders of the metabolism
- A61P3/08—Drugs for disorders of the metabolism for glucose homeostasis
- A61P3/10—Drugs for disorders of the metabolism for glucose homeostasis for hyperglycaemia, e.g. antidiabetics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P5/00—Drugs for disorders of the endocrine system
- A61P5/48—Drugs for disorders of the endocrine system of the pancreatic hormones
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D241/00—Heterocyclic compounds containing 1,4-diazine or hydrogenated 1,4-diazine rings
- C07D241/02—Heterocyclic compounds containing 1,4-diazine or hydrogenated 1,4-diazine rings not condensed with other rings
- C07D241/10—Heterocyclic compounds containing 1,4-diazine or hydrogenated 1,4-diazine rings not condensed with other rings having three double bonds between ring members or between ring members and non-ring members
- C07D241/14—Heterocyclic compounds containing 1,4-diazine or hydrogenated 1,4-diazine rings not condensed with other rings having three double bonds between ring members or between ring members and non-ring members with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
- C07D241/24—Carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals
- C07D241/26—Carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals with nitrogen atoms directly attached to ring carbon atoms
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D401/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom
- C07D401/02—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings
- C07D401/12—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings linked by a chain containing hetero atoms as chain links
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D403/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00
- C07D403/14—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00 containing three or more hetero rings
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D409/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having sulfur atoms as the only ring hetero atoms
- C07D409/02—Heterocyclic compounds containing two or more hetero rings, at least one ring having sulfur atoms as the only ring hetero atoms containing two hetero rings
- C07D409/06—Heterocyclic compounds containing two or more hetero rings, at least one ring having sulfur atoms as the only ring hetero atoms containing two hetero rings linked by a carbon chain containing only aliphatic carbon atoms
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07B—GENERAL METHODS OF ORGANIC CHEMISTRY; APPARATUS THEREFOR
- C07B2200/00—Indexing scheme relating to specific properties of organic compounds
- C07B2200/11—Compounds covalently bound to a solid support
Landscapes
- Health & Medical Sciences (AREA)
- Organic Chemistry (AREA)
- Chemical & Material Sciences (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Engineering & Computer Science (AREA)
- Animal Behavior & Ethology (AREA)
- Pharmacology & Pharmacy (AREA)
- Veterinary Medicine (AREA)
- Public Health (AREA)
- Chemical Kinetics & Catalysis (AREA)
- General Chemical & Material Sciences (AREA)
- Medicinal Chemistry (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- General Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Neurology (AREA)
- Biomedical Technology (AREA)
- Neurosurgery (AREA)
- Diabetes (AREA)
- Endocrinology (AREA)
- Psychiatry (AREA)
- Pain & Pain Management (AREA)
- Psychology (AREA)
- Reproductive Health (AREA)
- Emergency Medicine (AREA)
- Hematology (AREA)
- Hospice & Palliative Care (AREA)
- Dermatology (AREA)
- Obesity (AREA)
- Gynecology & Obstetrics (AREA)
- Orthopedic Medicine & Surgery (AREA)
- Physical Education & Sports Medicine (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Plural Heterocyclic Compounds (AREA)
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
SE0203753A SE0203753D0 (sv) | 2002-12-17 | 2002-12-17 | New compounds |
Publications (1)
Publication Number | Publication Date |
---|---|
TW200505905A true TW200505905A (en) | 2005-02-16 |
Family
ID=20289906
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
TW092134210A TW200505905A (en) | 2002-12-17 | 2003-12-04 | New compounds |
Country Status (23)
Country | Link |
---|---|
US (2) | US7595321B2 (zh) |
EP (1) | EP1575942B1 (zh) |
JP (1) | JP2006512337A (zh) |
KR (1) | KR20050084362A (zh) |
CN (1) | CN100360522C (zh) |
AR (1) | AR042343A1 (zh) |
AT (1) | ATE361291T1 (zh) |
AU (1) | AU2003287137B2 (zh) |
BR (1) | BR0317299A (zh) |
CA (1) | CA2508045A1 (zh) |
CY (1) | CY1106709T1 (zh) |
DE (1) | DE60313658T2 (zh) |
DK (1) | DK1575942T3 (zh) |
ES (1) | ES2285221T3 (zh) |
HK (1) | HK1080854A1 (zh) |
MX (1) | MXPA05006244A (zh) |
NO (1) | NO20053459L (zh) |
NZ (1) | NZ540450A (zh) |
PT (1) | PT1575942E (zh) |
SE (1) | SE0203753D0 (zh) |
TW (1) | TW200505905A (zh) |
WO (1) | WO2004055009A1 (zh) |
ZA (1) | ZA200504874B (zh) |
Families Citing this family (9)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US7704995B2 (en) | 2002-05-03 | 2010-04-27 | Exelixis, Inc. | Protein kinase modulators and methods of use |
SE0203752D0 (sv) | 2002-12-17 | 2002-12-17 | Astrazeneca Ab | New compounds |
SE0203753D0 (sv) | 2002-12-17 | 2002-12-17 | Astrazeneca Ab | New compounds |
CA2720659C (en) * | 2008-04-24 | 2016-10-18 | Abbott Gmbh & Co. Kg | 1-(7-(hexahydropyrrolo[3,4-c]pyrrol-2(1h)-yl)quinolin-4-yl)-3-(pyrazin-2-yl)urea derivatives and related compounds as glycogen synthase kinase 3 (gsk-3) |
EP2438041A4 (en) * | 2009-06-01 | 2012-11-21 | Merck Sharp & Dohme | PYRAZINE-carboxamide-orexin receptor Antagonist |
MX2012008328A (es) | 2010-01-19 | 2012-08-08 | Astrazeneca Ab | Derivados de pirazina. |
TWI712598B (zh) | 2016-07-20 | 2020-12-11 | 瑞士商諾華公司 | 胺基吡啶衍生物及其作為選擇性alk-2抑制劑之用途 |
PE20230251A1 (es) | 2019-11-22 | 2023-02-07 | Incyte Corp | Terapia de combinacion que comprende un inhibidor de alk2 y un inhibidor de jak2 |
JP2023530316A (ja) | 2020-06-16 | 2023-07-14 | インサイト・コーポレイション | 貧血の治療のためのalk2阻害剤 |
Family Cites Families (11)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US5472823A (en) * | 1992-01-20 | 1995-12-05 | Hitachi Chemical Co., Ltd. | Photosensitive resin composition |
JPH10152622A (ja) | 1996-11-26 | 1998-06-09 | Dainippon Ink & Chem Inc | ジスアゾ化合物およびジスアゾ顔料 |
MA26473A1 (fr) * | 1997-03-01 | 2004-12-20 | Glaxo Group Ltd | Composes pharmacologiquement actifs. |
DK1255740T3 (da) * | 2000-02-16 | 2006-02-06 | Neurogen Corp | Substituerede arylpyraziner |
NZ521207A (en) * | 2000-03-07 | 2005-04-29 | Aventis Pharma Gmbh | Substituted 3-phenyl-5-alkoxi-1,3,4-oxdiazol-2-one and use thereof for inhibiting hormone-sensitive lipase |
AR029489A1 (es) * | 2000-03-10 | 2003-07-02 | Euro Celtique Sa | Piridinas, pirimidinas, pirazinas, triazinas sustituidas por arilo, composiciones farmaceuticas y el uso de las mismas para la manufactura de un medicamento |
NZ528450A (en) * | 2001-05-11 | 2006-02-24 | Biovitrum Ab | Novel, arylsulfonamide compounds for the treatment of obesity, type II diabetes and CNS-disorders |
JP4901102B2 (ja) * | 2002-05-03 | 2012-03-21 | エクセリクシス, インク. | プロテインキナーゼモジュレーターおよびその使用方法 |
SE0203752D0 (sv) * | 2002-12-17 | 2002-12-17 | Astrazeneca Ab | New compounds |
SE0203754D0 (sv) * | 2002-12-17 | 2002-12-17 | Astrazeneca Ab | New compounds |
SE0203753D0 (sv) | 2002-12-17 | 2002-12-17 | Astrazeneca Ab | New compounds |
-
2002
- 2002-12-17 SE SE0203753A patent/SE0203753D0/xx unknown
-
2003
- 2003-12-04 TW TW092134210A patent/TW200505905A/zh unknown
- 2003-12-09 AR ARP030104528A patent/AR042343A1/es unknown
- 2003-12-15 AU AU2003287137A patent/AU2003287137B2/en not_active Ceased
- 2003-12-15 MX MXPA05006244A patent/MXPA05006244A/es active IP Right Grant
- 2003-12-15 ES ES03781206T patent/ES2285221T3/es not_active Expired - Lifetime
- 2003-12-15 PT PT03781206T patent/PT1575942E/pt unknown
- 2003-12-15 NZ NZ540450A patent/NZ540450A/en unknown
- 2003-12-15 CN CNB2003801064833A patent/CN100360522C/zh not_active Expired - Fee Related
- 2003-12-15 KR KR1020057011135A patent/KR20050084362A/ko not_active Application Discontinuation
- 2003-12-15 EP EP03781206A patent/EP1575942B1/en not_active Expired - Lifetime
- 2003-12-15 BR BR0317299-6A patent/BR0317299A/pt not_active IP Right Cessation
- 2003-12-15 AT AT03781206T patent/ATE361291T1/de not_active IP Right Cessation
- 2003-12-15 DE DE60313658T patent/DE60313658T2/de not_active Expired - Lifetime
- 2003-12-15 JP JP2004560225A patent/JP2006512337A/ja active Pending
- 2003-12-15 CA CA002508045A patent/CA2508045A1/en not_active Abandoned
- 2003-12-15 DK DK03781206T patent/DK1575942T3/da active
- 2003-12-15 US US10/539,545 patent/US7595321B2/en not_active Expired - Fee Related
- 2003-12-15 WO PCT/SE2003/001957 patent/WO2004055009A1/en active IP Right Grant
-
2005
- 2005-06-14 ZA ZA200504874A patent/ZA200504874B/en unknown
- 2005-07-15 NO NO20053459A patent/NO20053459L/no not_active Application Discontinuation
-
2006
- 2006-01-18 HK HK06100841A patent/HK1080854A1/xx not_active IP Right Cessation
-
2007
- 2007-07-04 CY CY20071100890T patent/CY1106709T1/el unknown
-
2009
- 2009-09-28 US US12/568,266 patent/US20100087396A1/en not_active Abandoned
Also Published As
Publication number | Publication date |
---|---|
CN1726210A (zh) | 2006-01-25 |
PT1575942E (pt) | 2007-07-09 |
ZA200504874B (en) | 2006-04-26 |
SE0203753D0 (sv) | 2002-12-17 |
WO2004055009A8 (en) | 2005-06-30 |
ATE361291T1 (de) | 2007-05-15 |
BR0317299A (pt) | 2005-11-08 |
US20100087396A1 (en) | 2010-04-08 |
US7595321B2 (en) | 2009-09-29 |
EP1575942B1 (en) | 2007-05-02 |
CN100360522C (zh) | 2008-01-09 |
AU2003287137B2 (en) | 2007-07-05 |
JP2006512337A (ja) | 2006-04-13 |
ES2285221T3 (es) | 2007-11-16 |
MXPA05006244A (es) | 2005-08-19 |
AU2003287137A1 (en) | 2004-07-09 |
KR20050084362A (ko) | 2005-08-26 |
DE60313658T2 (de) | 2008-01-10 |
NZ540450A (en) | 2007-10-26 |
AR042343A1 (es) | 2005-06-15 |
CY1106709T1 (el) | 2012-05-23 |
CA2508045A1 (en) | 2004-07-01 |
DE60313658D1 (de) | 2007-06-14 |
HK1080854A1 (en) | 2006-05-04 |
WO2004055009A1 (en) | 2004-07-01 |
EP1575942A1 (en) | 2005-09-21 |
NO20053459L (no) | 2005-08-12 |
US20060116385A1 (en) | 2006-06-01 |
DK1575942T3 (da) | 2007-09-03 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
WO2004055005A8 (en) | Novel compounds having selective inhibiting effect at gsk3 | |
EE200300403A (et) | N-asendatud mittearomaatne heterotsükliline ühend, seda sisaldav ravimkompositsioon ning ühendi kasutamine ravimina | |
AP2001002299A0 (en) | Aryl or heteroaryl fused imidazole compounds as anti-inflammatory and analgesic agents. | |
SE0102438D0 (sv) | New compounds | |
CY1108823T1 (el) | Παραγωγα 2-υδροξυ-3-ετεροαρυλινδολης ως αναστολεις της gsk3 | |
SE0102439D0 (sv) | New compounds | |
NO20053459L (no) | Nye forbindelser med selektiv inhiberende effekt av GSK3 | |
NO20060383L (no) | Substituerte diketopiperaziner og deres anvendelse som oksytocinantagonister | |
NO304113B1 (no) | Krystallinsk tiagabinhydrokloridmonohydrat, farmas°ytisk preparat som omfatter det, og anvendelse derav for fremstilling av et medikament | |
SE9701304D0 (sv) | Compounds | |
TW200420292A (en) | Benzofuran derivative | |
AU2001246999A1 (en) | New neurokinin antagonists for use as medicaments | |
HU9802897D0 (en) | Optically active pyridyl-4h-1,2,4-oxadiazine derivatives, the use thereof in the treatment of vascular diseases and pharmaceutical composition containing the compound as active ingredient | |
DK0728138T3 (da) | Anthracyclinderivater | |
BR0112957A (pt) | Composto, método de tratamento, uso de um composto, e, composição farmacêutica | |
SE0004827D0 (sv) | Therapeutic compounds | |
AU2001244999A1 (en) | Naphthamide neurokinin antagonists for use as medicaments | |
HUP0203476A2 (en) | Sodium 2-(4,6-dimethyl-pyrimidin-2-yloxy)-3-(2-(3,4-dimethoxyphenyl)ethoxy)-3,3-diphenylpropionate, use thereof and pharmaceutical composition containing the same |